Professor Stefan Klaus Bohlander

Selected publications and creative works (Research Outputs)

  • Barbosa, K., Deshpande, A., Chen, B.-R., Ghosh, A., Sun, Y., Dutta, S., ... Bohlander, S. K. (2019). Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1. Experimental hematology, 74, 42-51.e3. 10.1016/j.exphem.2019.04.003
  • Hunter, F. W., Devaux, J. B. L., Meng, F., Hong, C. R., Khan, A., Tsai, P., ... Marastoni, S. (2019). Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide. Molecular pharmacology, 95 (6), 638-651. 10.1124/mol.118.115196
    Other University of Auckland co-authors: Francis Hunter, Jules Devaux, Peter Tsai, Cristin Print
  • Lipert, B., Siemens, K. N., Khan, A., Barker, H. R., Tsai, P., Ketela, T. W., ... Hunter, F. W. (2019). Functional CRISPR knockout screens for modifiers of sensitivity to trastuzumab emtansine. Paper presented at ESMO Breast Cancer, Berlin, GERMANY. 2 May - 4 May 2019. ANNALS OF ONCOLOGY. (pp. 1).
    Other University of Auckland co-authors: Stephen Jamieson
  • Angenendt, L., Bormann, E., Pabst, C., Alla, V., Görlich D, Braun, L., ... Arteaga, M. F. (2019). The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia. Leukemia10.1038/s41375-019-0505-x
  • Lange, A. P., Almeida, L. Y., Araújo Silva CL, Scheucher, P. S., Chahud, F., Krause, A., ... Rego, E. M. (2019). CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 52 (6)10.1590/1414-431X20198424
  • Vosberg, S., Hartmann, L., Metzeler, K. H., Konstandin, N. P., Schneider, S., Varadharajan, A., ... Bohlander, S. K. (2018). Relapse of acute myeloid leukemia after allogeneic stem cell transplantation is associated with gain of WT1 alterations and high mutation load. Haematologica, 103 (12), e581-e584. 10.3324/haematol.2018.193102
  • Braess, J., Amler, S., Kreuzer, K.-A., Spiekermann, K., Lindemann, H. W., Lengfelder, E., ... Biersack, H. (2018). Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study. Leukemia, 32 (12), 2558-2571. 10.1038/s41375-018-0268-9
  • Hornung, R., Jurinovic, V., Batcha, A. M. N., Bamopoulos, S. A., Rothenberg-Thurley, M., Amler, S., ... BohlanderSK (2018). Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Scientific Reports, 8 (1).10.1038/s41598-018-29593-2

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 3, Room 339A
New Zealand